01.21

Registered a domestic patent for WS1315D

01.22

Certified as Inno-Biz by Ministry of SMEs and Startups

05.01

Signed MOU for technology development
with Gyeonggi Business & Science Accelerator

12.12

Received a citation for contributing to the development
of the venture industry

12.13

Designated as a Promising SME in Gyeonggi-do

Applied for PCT international patent for WS1315D

01.24

Received pharmaceutical wholesaler license

04.03

Approved as corporate research institute by KOITA

06.22

Signed MOU for startup technology development
project with Ministry of SMEs and Startups

06.28

Obtained marketing authorization for “Profa Infusion Inj.
Non-PVC Bag,” Korea’s first acetaminophen injection

07.29

Received a citation from the head of Gyeonggi Regional
SMEs and Startups

12.13

02.22

Certified as Venture Company by Korea Technology
Finance Corporation

03.17

Obtained marketing authorization approved for
“Profa Infusion Inj.”(Chief ingredient: acetaminophen),
which is Korea’s first acetaminophen antipyretic
analgesic injection

05.28

Signed MOU for startup technology development project
with Small and Medium Business Administration

Obtained marketing authorization approved for
5-Ingredient mineral injection, first generic
“Pentablue-5 Injection” (Ingredients: Zinc, Copper,
Manganese, Selenium, Chromium)

04.05

Certified as dedicated corporate research
institute by KOITA

06.03

01.29

Woosung Pharma. Inc. was founded